Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
Winette T.A. van der Graaf(Radboud University Medical Center), Jean‐Yves Blay(Centre Léon Bérard), Sant P. Chawla(Sarcoma Oncology Center), Dong‐Wan Kim(Seoul National University Hospital), B. Bui-Nguyen(Institut Bergonié), Paolo G. Casali(Fondazione IRCCS Istituto Nazionale dei Tumori), Patrick Schöffski(KU Leuven), Massimo Aglietta(Candiolo Cancer Institute), Arthur P. Staddon(University of Pennsylvania), Yasuo Beppu(Tokyo National Hospital), Axel Le Cesne(Institut Gustave Roussy), Hans Gelderblom(Leiden University Medical Center), Ian Judson(Royal Marsden NHS Foundation Trust), Nobuhito Araki, M. Ouali(European Organisation for Research and Treatment of Cancer), Sandrine Marréaud(European Organisation for Research and Treatment of Cancer), Rachel Hodge(GlaxoSmithKline (United Kingdom)), Mohammed R Dewji(GlaxoSmithKline (United Kingdom)), Corneel Coens(European Organisation for Research and Treatment of Cancer), George D. Demetri(Dana-Farber Cancer Institute), Christopher D.�M. Fletcher(Brigham and Women's Hospital), Angelo Paolo Dei Tos(Ca' Foncello Hospital), Peter Hohenberger(Heidelberg University)
Cited by 2,081Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis